Follow DNDi on LinkedInFollow DNDi on TwitterFollow DNDi on Facebook

Donors

DNDi is grateful for the support received from the following donors who contributed toward the advancement of its mission and goals. To date, DNDi has delivered six new treatments and aims to bring eleven to thirteen treatments in total to patients suffering from neglected diseases by 2018.  DNDi would like to thank all of the donors and partners for their loyal commitment and partnership since 2003.

THANKS TO OUR DONORS

  • Public Institutional Donors
  • Private Donors
  • Private Foundations and Private Individual Donors
 



PUBLIC INSTITUTIONAL DONORS

Department for International Development (DFID) / UNITED KINGDOM
• Grant period: 2013-2018
• Support to DNDi initiative
• Total amount: GBP 30 million
• www.dfid.gov.uk
• Link to press release

• Grant period: 2009-2013
• Support to DNDi initiative
• Total amount: GBP 24.9 million
• www.dfid.gov.uk
• Link to press release

• Grant period: 2006-2008
• Support to DNDi initiative
• Total amount: GBP 6.5 million
• www.dfid.gov.uk


Dutch Ministry of Foreign Affairs (DGIS) / THE NETHERLANDS 
• Grant period: 2011-2014
• Support to DNDi’s disease programmes for human African trypanosomiasis (HAT), Chagas disease, and leishmaniasis (from screening to clinical studies and implementation for new and improved products).
• Total amount: EUR 14 million
• www.minbuza.nl/en/ministry 
• Link to press release

• Grant period: 2006-2010
• Support to DNDi malaria project (FACT)
• Total amount: EUR 2.9 million
• www.minbuza.nl/en/ministry 


European and Developing Countries Clinical Trials Partnership (EDCTP) / EUROPE
• Grant period: 2010-2014
• Support to clinical studies for the assessment of the fixed-dose combination of ASMQ as an alternative antimalarial treatment for children in Africa
• Total amount: EUR 577,900 
• www.edctp.org 


European Union - Framework Programme 5 and 6
• Grant period: 2004-2006 / 2006-2009
• Support to DNDi malaria project (FACT) / to the Human African Trypanosomiasis Platform
• Total amount: EUR 241,300 / EUR 340,000
• cordis.europa.eu/inco/home_en.html 
ec.europa.eu/research/iscp/index.cfm 


European Union - Framework Programme 7
• Grant period: 2009-2012
• Support to LEISHDNAVAX - Development of a DNA vaccine for visceral leishmaniasis
• Total amount: EUR 253,800 
• http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/projects/006_en.html 


European Union - Framework Programme 7
• Grant period: 2013-2015
• Support to AfriCoLeish - Development of a care package for treatment and control of visceral leishmaniasis in East Africa
• Total amount: EUR 3 million
• Link to press release 

• cordis.europa.eu/projects/rcn/106176_en.html


French Development Agency (AFD) / FRANCE 
• Grant period: 2012-2017
• Support to specific projects in Africa: technology transfer of ASAQ for Malaria, clinical trials for ASMQ (Malaria), development of a new oral treatment for human African trypanosomiasis (HAT), support to the HAT Platform and development of a new paediatric formulation of HIV
• Total amount : EUR 5 million
• www.afd.fr

• Grant period: 2006-2010
• Support to DNDi malaria project (FACT)
• Total amount : EUR 2 million
• www.afd.fr
• Link to initial press release


Global Fund To fight AIDS, Tuberculosis and Malaria / INTERNATIONAL
• Grant period: 2010-2012
• Support to the Baseline and Endpoint Survey Work for the Independent Evaluation of Phase 1 of the Affordable Medicines Facility - malaria (AMFm) in Ghana
• Total amount: EUR 532,800
• www.theglobalfund.org/en/


Global Health Innovative Technology (GHIT) / JAPAN

• Grant period: 2013
• Support to screening activities
• Total amount: USD 158,000

• Grant period: 2013-2014
• Support to DNDi Chagas disease programme in joint collaboration with Eisai (E1224 combination study & benznidazole)
• Total amount: EUR 2.8 million


GiZ on behalf of the Government of the Federal Republic of Germany / GERMANY

• Grant period: 2008–2009 
• Support to specific discovery, preclinical/clinical projects (screening, lead optimisation for Chagas disease, Fexinidazole for human African trypanosomiasis)
• Total amount: EUR 1 million
• www.giz.de/en/


Federal Ministry of Education and Research (BMBF) through KfW / GERMANY and part of the EDCTP2 programme supported by the European Union
• Grant period: 2011-2014 
• Support to DNDi’s disease programmes for human African trypanosomiasis, Chagas disease, leishmaniasis and filarial diseases (from screening to clinical studies for new and improved products) 
• Total amount: EUR 8 million
• www.bmbf.de
• Link to BMBF press release and DNDi press release


Ministry of Foreign and European Affairs (MAEE) / FRANCE 
• Grant period: 2009-2011
• Support to specific discovery and lead optimisation projects for human African trypanosomiasis, Chagas disease, and leishmaniasis 
• Total amount: EUR 1.3 million
• www.diplomatie.gouv.fr/fr/

• Grant period: 2007-2010
• Support DNDi’s disease programmes for human African trypanosomiasis and visceral leishmaniasis in Africa (preclinical, clinical and implementation activities and capacity building.) 
• Total amount: EUR 5.9 million 
• www.diplomatie.gouv.fr/fr/


Ministry of Health / BRAZIL
• Grant period: 2013 
• Support to DNDi initiative & Chagas disease
• Total amount: EUR 275,000


National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) / UNITED STATES OF AMERICA
• Grant period: 2010-2013
• Support to preclinical activities (K777 project) for Chagas disease
• Total amount: USD 1.2 million

• Grant period: 2007-2012
• Support to Amphotericin B Polymer project for visceral leishmaniasis
• Total amount: USD 1.5 million
• www.nih.gov/ http://www3.niaid.nih.gov/
• Link to press release


The Norwegian Agency for Development Cooperation (Norad) / NORWAY

• Grant period: 2013-2015
• Support to DNDi’s disease programme for human African trypanosomiasis
• Total amount: NOK 15 million
• Link to press release


Region of Tuscany / ITALY
• Grant period: 2007-2008 
• Support to the development of SSG&PM (Paromomycin project) and capacity strengthening for visceral leishmaniasis
• Total amount: EUR 200,000 
• www.regione.toscana.it/prehome_1024.htm 


Republic and Canton of Geneva, Institution Department, International Solidarity / SWITZERLAND 
• Grant period: 2013-2015 
• Support to  HAT (human African trypanosomiasis) activities 
• Total amount: CHF 500,000 

• Grant period: 2010-2012 
• Support to the implementation of NECT (NECT-Field project) for human African trypanosomiasis
• Total amount: CHF 600,000 

• Grant period: 2004-2009
• Support to the development of SSG&PM (paromomycin project) for visceral leishmaniasis
• Total amount: CHF 1 million
• www.ge.ch


Spanish Agency for International Development Cooperation (AECID) / SPAIN

• Grant period: 2007-2012
• Support to DNDi initiative
• Total amount: EUR 12 million
• www.aecid.es/es/


Swiss Agency for Development and Cooperation (SDC) / SWITZERLAND
• Grant period: 2013-2016
• Support to DNDi initiative
• Total amount: CHF 8 million
• www.deza.ch/en/Home  

• Grant period: 2012-2013
• Support to DNDi Malaria programme
• Total amount: CHF 900,000
• www.deza.ch/en/Home 

• Grant period: 2010-2012
• Support to DNDi initiative
• Total amount: CHF 4 million
• www.deza.ch/en/Home 
• Link to press release

• Grant period: 2005-2006
• Support to DNDi Malaria programme
• Total amount: CHF 120,000
• www.deza.ch/en/Home 


PRIVATE DONORS


Bill & Melinda Gates Foundation / UNITED STATES OF AMERICA
• Grant period: 2013-2014
• Total amount: USD 1 million
• Support to DNDi activities through the "Innovative Fund Award"
• www.gatesfoundation.org/default.htm 


• Grant period: 2011-2015
• Total amount: USD 9 million
• Support to the adoption and implementation of new treatment options for visceral leishmaniasis in Asia
• www.gatesfoundation.org/default.htm 
• Link to press release


• Grant period: 2011-2014
• Total amount: USD 4.3 million
• Support to the pre-clinical development of a macrofilaricidal drug candidate (flubendazole) for filarial diseases
• www.gatesfoundation.org/default.htm 
• Link to press release


• Grant period: 2011-2013
• Total amount: USD 2 million
• Support to screening for neglected tropical diseases
• www.gatesfoundation.org/default.htm 


• Grant period: 2013-2014
• Total amount: USD 2.3 million
• Support to identify new drug candidate for filarial diseases (supplemental grant to the grant to support screening for NTDs)
• www.gatesfoundation.org/default.htm 


• Grant period: 2009-2014
• Total amount: USD 15 million
• Support to the clinical development of fexinidazole for human African trypanosomiasis
• www.gatesfoundation.org/default.htm 
• Link to press release


• Grant period: 2007-2012
• Total amount: USD 27.2 million
• Support to lead optimisation, preclinical and start of clinical activities for human African trypanosomiasis/visceral leishmaniasis
• www.gatesfoundation.org/default.htm 
• Link to press release


Médecins Sans Frontières (Doctors without Borders) / INTERNATIONAL
• Grant period: 2014-2018
• Total amount: EUR 20 million
• Support to DNDi initiative
• www.msf.org


• Grant period: 2009-2013
• Total amount: EUR 18.4 million
• Support to DNDi initiative
• www.msf.org


• Grant period: 2003-2008
• Total amount: EUR 25 million
• Support to DNDi initiative
• www.msf.org
• Link to press release


Médecins Sans Frontières (Doctors without Borders) / ITALY
• Grant period: 2010-2011
• Total amount: EUR 600,000
• Support to the development and registration of the paediatric dosage form of benznidazole for Chagas disease
• www.medicisenzafrontiere.it/
• Link to press release

• Grant period: 2009
• Total amount: EUR 100,000
• Support to DNDi malaria project (FACT) - study in Liberia with ASAQ
• www.medicisenzafrontiere.it/
• Link to press release


Médecins Sans Frontières (Doctors without Borders) / NORWAY
• Grant period: 2011-2013
• Total amount: EUR 1,135,000
• Support to R&D for paediatric HIV programme
• www.leger-uten-grenser.no 

• Grant period: 2010
• Total amount: EUR 165,000
• Support to R&D opportunities for filarial diseases and paediatric HIV programmes
• www.leger-uten-grenser.no 


Médecins Sans Frontières (Doctors without Borders) / BRAZIL
• Grant period: 2011-2012
• Total amount: R$ 1 million
• Support to the development and registration of the paediatric dosage form of benznidazole for Chagas disease
• www.msf.org.br

The Wellcome Trust / UNITED KINGDOM 
• Grant period: 2011-2014
• Total amount: EUR 1,999,801
• Support to the Phase II clinical trial of E1224 for Chagas disease
• www.wellcome.ac.uk
• Link to press release

• Grant period: 2012-2015
• Total amount: USD 3,000,000 + USD 85'182 as supplemental funding
• Support to a study to validate PCR and other biomarkers for Chagas disease
• www.wellcome.ac.uk


PRIVATE FOUNDATIONS AND PRIVATE INDIVIDUAL DONORS

Carlos Slim Foundation (through the Carlos Slim Health Award) / MEXICO
• Grant period: 2013
• Total amount: USD 100,000
• Support to Chagas programme
• Link to press release


Rockefeller Foundation (through the "Next Century Innovators Award") / USA
• Grant period: 2013
• Total amount: USD 100,000
• Support to DNDi initiative
• Link to press release


BBVA Foundation (through the "Frontiers of Knowledge Award in Development Cooperation") / SPAIN
• Grant period: 2012
• Total amount: EUR 400,000
• Support to DNDi initiative
• Link to press release


Medicor Foundation / LIECHTENSTEIN
• Grant period: 2009-2013
• Total amount: USD 2.3 million
• Support to VL programmes in Africa
• www.medicor.li/en

• Grant period: 2007
• Total amount: EUR 650,000
• Support to VL programmes in Africa
• www.medicor.li/en


Fondation André & Cyprien / SWITZERLAND 


The Sasakawa Peace Foundation / JAPAN


The Starr International Foundation / SWITZERLAND


Sandoz Family Foundation


Wellspring Advisor


and others that would like to remain anonymous.

top of the page

Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site
is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License